Marco Salvetti

Pubblicazioni

Titolo Pubblicato in Anno
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS FRONTIERS IN NEUROLOGY 2022
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION 2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease BioRxiv 2022
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease FRONTIERS IN NEUROLOGY 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis MULTIPLE SCLEROSIS AND RELATED DISORDERS 2022
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies JOURNAL OF NEUROLOGY 2022
Distal upper limb involvement in myasthenia-myositis association NEUROLOGICAL SCIENCES 2022
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment JOURNAL OF NEURAL TRANSMISSION 2022
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures JOURNAL OF NEUROSURGICAL SCIENCES 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosis EUROPEAN JOURNAL OF NEUROLOGY 2022
CADASIL or MS? Consider “Red Flags” but Avoid a Misdiagnosis: Case Series of a Concomitant Diagnosis ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review FRONTIERS IN NEUROLOGY 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study MULTIPLE SCLEROSIS AND RELATED DISORDERS 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register MULTIPLE SCLEROSIS 2022
Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists FRONTIERS IN NEUROLOGY 2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets CURRENT NEUROPHARMACOLOGY 2022
Machine Learning use for prognostic purposes in Multiple Sclerosis LIFE 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation MULTIPLE SCLEROSIS 2021
Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal NATURE REVIEWS. NEUROLOGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma